A commonly used formula that overestimates the risk for a cardiac adverse event can lead to inappropriate chemotherapy decisions, according to a study published in  JAMA Oncology .

Many cancer drugs carry a risk for QT interval prolongation, which predisposes patients to fatal heart arrhythmias. Because of this risk, patients with cancer often undergo...